Inventor · disambiguated record
Wenyu Zhu
Also filed as: ZHU WENYU
44 granted patents·23 pending applications·931 citations·filing 2004–2025
98Inventor score
Top patents by PatentIndex Score
67 records- 0199US9181271B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 10, 2015·105 cites·6 claims
- 0298US8933085B2Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted Jan 13, 2015·96 cites·39 claims
- 0398US8716303B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsRODGERS JAMES D·Filed 2010·Granted May 6, 2014·109 cites·74 claims
- 0498US8088803B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2009·Granted Jan 3, 2012·64 cites·30 claims
- 0597US10806785B2Immunomodulator compounds and methods of useINCYTE CORP·Filed 2017·Granted Oct 20, 2020·32 cites·17 claims
- 0697US10092570B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2017·Granted Oct 9, 2018·17 cites·20 claims
- 0797US9730939B2Heterocyclylamines as PI3K inhibitorsINCYTE CORP·Filed 2015·Granted Aug 15, 2017·23 cites·7 claims
- 0897US9540347B2Pyridineamine compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jan 10, 2017·19 cites·70 claims
- 0997US9334274B2N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitorsINCYTE CORP·Filed 2014·Granted May 10, 2016·57 cites·34 claims
- 1097US9034884B2Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitorsRODGERS JAMES D·Filed 2011·Granted May 19, 2015·91 cites·36 claims
- 1197US8993605B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2014·Granted Mar 31, 2015·34 cites·15 claims
- 1296US9320732B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2015·Granted Apr 26, 2016·14 cites·9 claims
- 1396US8822511B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2013·Granted Sep 2, 2014·24 cites·36 claims
- 1495US9789094B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2016·Granted Oct 17, 2017·11 cites·23 claims
- 1595US8796319B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2011·Granted Aug 5, 2014·21 cites·68 claims
- 1694US10034864B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2017·Granted Jul 31, 2018·8 cites·20 claims
- 1794US9193733B2Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitorsINCYTE CORP·Filed 2013·Granted Nov 24, 2015·33 cites·48 claims
- 1893US11530218B2Spiro compounds as inhibitors of KRASINCYTE CORP·Filed 2021·Granted Dec 20, 2022·3 cites·42 claims
- 1993US9920032B2Heterocyclic compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Mar 20, 2018·12 cites·31 claims
- 2093US9777017B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Oct 3, 2017·9 cites·20 claims
- 2192US10370387B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2018·Granted Aug 6, 2019·6 cites·15 claims
- 2292US10369137B21,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2018·Granted Aug 6, 2019·5 cites·4 claims
- 2392US10000507B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2016·Granted Jun 19, 2018·12 cites·18 claims
- 2492US9908895B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2015·Granted Mar 6, 2018·8 cites·2 claims
- 2592US8951536B2N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2013·Granted Feb 10, 2015·25 cites·17 claims
- 2691US11851442B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2021·Granted Dec 26, 2023·1 cites·12 claims
- 2791US10653677B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2019·Granted May 19, 2020·4 cites·20 claims
- 2891US9556197B2Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitorsINCYTE CORP·Filed 2014·Granted Jan 31, 2017·19 cites·48 claims
- 2991US2025325550A1Heterocyclylamines as pi3k inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 3090US8450351B2N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenaseCOMBS ANDREW P·Filed 2006·Granted May 28, 2013·18 cites·30 claims
- 3189US11161850B2Fused pyrazine derivatives as A2A / A2B inhibitorsINCYTE CORP·Filed 2019·Granted Nov 2, 2021·5 cites·12 claims
- 3288US10450296B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2018·Granted Oct 22, 2019·6 cites·25 claims
- 3388US2024173303A11,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- DioxygenaseINCYTE CORP·Filed 2023·Application pending·0 cites
- 3488US2024228508A1Tricyclic fused thiophene derivatives as jak inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 3587US7141596B2Inhibitors of proteins that bind phosphorylated moleculesINCYTE CORP·Filed 2004·Granted Nov 28, 2006·24 cites·61 claims
- 3686US11207302B21,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenaseINCYTE CORP·Filed 2020·Granted Dec 28, 2021·1 cites·20 claims
- 3786US11161855B2Tricyclic fused thiophene derivatives as JAK inhibitorsINCYTE CORP·Filed 2019·Granted Nov 2, 2021·3 cites·54 claims
- 3886US2025289823A1Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disordersINCYTE CORP·Filed 2024·Application pending·0 cites
- 3982US8871753B2Macrocyclic compounds and their use as kinase inhibitorsCOMBS ANDREW PAUL·Filed 2009·Granted Oct 28, 2014·8 cites·62 claims
- 4080US11939328B2Quinoline compounds as inhibitors of KRASINCYTE CORP·Filed 2022·Granted Mar 26, 2024·0 cites·35 claims
- 4180US11053215B2Heterocyclic compounds useful as Pim kinase inhibitorsINCYTE CORP·Filed 2019·Granted Jul 6, 2021·1 cites·12 claims
- 4280US2022331296A11,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- DioxygenaseINCYTE CORP·Filed 2021·Application pending·0 cites
- 4379US12378243B2Quinoline compounds as inhibitors of KRASINCYTE CORP·Filed 2024·Granted Aug 5, 2025·0 cites·34 claims
- 4478US8765727B2Macrocyclic compounds and their use as kinase inhibitorsCOMBS ANDREW PAUL·Filed 2010·Granted Jul 1, 2014·3 cites·64 claims
- 4576US2025325660A1Immunomodulator compounds and methods of useINCYTE CORP·Filed 2025·Application pending·0 cites
- 4676US2025041310A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4775US12030884B2Pyrazoloquinoline KRAS inhibitorsINCYTE CORP·Filed 2022·Granted Jul 9, 2024·0 cites·26 claims
- 4875US2024360140A1Fused pyrazine derivatives as a2a / a2b inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 4975US2025059293A1Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2024·Application pending·0 cites
- 5074US2025368641A1Quinoline compounds as inhibitors of krasINCYTE CORP·Filed 2025·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wenyu Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →